Instead of accepting inconsistent results, proactively address the root causes. Variability is a problem that can be solved through better raw material selection, improved process design, or increased lab automation, leading to more reproducible and reliable outcomes.
The success of outsourcing bioprocesses often hinges on managing interpersonal dynamics and team collaboration, which are frequently underestimated compared to technical challenges. The human element, including politics between companies, is a major pitfall where tech transfer projects struggle.
Instead of a jarring switch, gradually integrate GMP-like practices into daily operations, such as structured documentation and a quality-focused culture. This proactive approach smooths the eventual transition into a regulated framework without 'overkilling it' with excessive early investment.
Lab-scale processes often contain methods, like certain purifications, that are not commercially scalable. It is critical to identify and redevelop these elements early to avoid hitting a manufacturing wall, even if it introduces temporary changes to the product profile.
